Connect with us
The current round will enable Arjuna Therapeutics to carry out its developments and later open a new round of financing on an international scale. The round...
Ability Pharma is working on a drug capable of inducing cancer cell death through autophagy. ABTL0812 has demonstrated clinical efficacy in a Phase II clinical trial...
CaixaResearch promotes cutting-edge research in health and biomedicine. The "la Caixa" Foundation's call for health research supports 33 projects of excellence from universities and research centers...
The Spanish biotech company Cebiotex has opened a financing round. The company hopes to use the economic resources obtained to reach the second clinical phase of...
Celyad Oncology—a biotech startup creating a highly specialized treatment for relapsing multiple myeloma patients—has just had its clinical trial validated by the FDA. A major milestone...
Celyad Oncology has just had a clinical trial validated by the FDA, a major milestone in the development of Nasdaq-listed biotech company. On Tuesday, July 14th,...
The Liège-based biotech company PDC*line Pharma, which specializes in immuno-oncology, has initiated a Phase I/II study to evaluate a therapeutic vaccine against lung cancer. This cancer...
Marijuana has been used as a medicinal herb for centuries and the DEA categorizes the plant as a Schedule 1 controlled substance. However, some states permit...
A new combination of drugs has brought good news for both ovarian and lung cancer patients.